Shares of ResMed Inc. RMD slipped 0.26% to $249.33 Wednesday, on what proved to be an all-around rough trading session for ...

ResMed Inc. is downgraded from buy to watchful hold due to valuation concerns, despite strong financial performance and ...

Analyzing ResMed Inc.'s Q1 2025 results, stock performance, and sentiment to determine if further upside or profit taking is ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update.Don't Miss our Black Friday ...

Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (AU:RMD) has released an update. Desney Tan, a ...

With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of medical devices and cloud-based software for the treatment of sleep ...

With a market cap of $35.8 billion, ResMed Inc. (RMD) is a global leader in the design, manufacturing, and distribution of ...

Shares of ResMed Inc. RMD advanced 2.37% to $249.56 Monday, on what proved to be an all-around great trading session for the stock market, with the S&P 500 Index SPX rising 0.30% to 5,987.37 and ...

ResMed Inc.’s RMD robust performance of its Mask business is supported by continued product development within the portfolio. Its Software-as-a-Service (SaaS) business continues to benefit from ...

ResMed Inc., a key player in the American Medical Equipment industry, is set to host its Annual General Meeting (AGM) on November 16th. The upcoming AGM presents an opportunity for... On November ...

ResMed, Inc. engages in providing digital health and cloud-connected medical devices. Its digital health technologies and cloud-connected medical devices transform care for people with sleep apnea ...

Chief Product Officer at ResMed Inc . (NYSE:RMD), has sold 6,160 shares of the company's common stock, according to a recent SEC filing. The... SAN DIEGO, CA – ResMed Inc . (NYSE:RMD), a medical ...